NEW YORK, NY / ACCESSWIRE / January 9, 2019 / U.S. equities closed up on Tuesday as market participants await details from the recent negotiations in Washington between U.S. and senior Chinese officials. According to Bloomberg, Chinese Vice Premier Liu He, who is considered to be a top adviser to Chinese President Xi Jinping, was in attendance. Dow Jones Industrial Average gained 1.09 percent to settle at 23,787.45, while S&P 500 increased 0.97 percent to close at 2,574.41. Nasdaq jumped 1.08 percent to close at 6,897.00.
According to the strategists at MRB Partners, "The U.S.-China power struggle will persist for years, but both economies are now slowing and neither government has the latitude to pursue policies that could threaten to trigger a global recession. The Argentina handshake will morph into a near-term truce."
The Market Edge Initiates Coverage on:
Tandem Diabetes Care, Inc.
Tandem Diabetes Care's stock jumped 8.43% Tuesday, to close the day at $40.00. The stock recorded a trading volume of 2,448,112 shares, which was above its three months average volume of 1,713,009 shares. In the last year, Tandem Diabetes Care's shares have traded in a range of 2.14 - 52.55. The share price has gained 1769.16% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $34.58 is below its 200-day moving average of $34.59. Shares of Tandem Diabetes Care have gained roughly 19.44 percent in the past month and are up 7.21 percent year-to-date.
Access The Market Edge's Tandem Diabetes Care, Inc. Research Report:
On Tuesday, shares of Medtronic recorded a trading volume of 14,472,170 shares, which was above the three months average volume of 5,861,455 shares. The stock ended the day 0.7% higher at $83.03. The share price has fallen 17.09% from its 52 week high with a 52 week trading range of 76.41 - 100.15. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $92.26 is below its 200-day moving average of $92.50. Shares of the company are trading at a Price to Earnings ratio of 52.09. Shares of Medtronic have fallen roughly 11.9 percent in the past month and are down 8.72 percent year-to-date.
Access The Market Edge's Medtronic plc Research Report:
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered
For any questions, inquiries, or comments reach out to us directly at:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: The Market Edge